Medpace Holdings Inc
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- $277.195
- Today's High:
- $281.84
- Open Price:
- $277.61
- 52W Low:
- $141.3
- 52W High:
- $281.84
- Prev. Close:
- $279.35
- Volume:
- 220902
Company Statistics
- Market Cap.:
- $8.54 billion
- Book Value:
- 12.825
- Revenue TTM:
- $1.67 billion
- Operating Margin TTM:
- 19.06%
- Gross Profit TTM:
- $925.11 million
- Profit Margin:
- 16.06%
- Return on Assets TTM:
- 14.64%
- Return on Equity TTM:
- 79.68%
Company Profile
Medpace Holdings Inc had its IPO on 2016-08-11 under the ticker symbol MEDP.
The company operates in the Healthcare sector and Diagnostics & Research industry. Medpace Holdings Inc has a staff strength of 5,600 employees.
Stock update
Shares of Medpace Holdings Inc opened at $277.61 at the start of the last trading session i.e. 2023-09-12.
The stocks traded within a range of $277.2 - $281.84, and closed at $279.54.
This is a +0.07% increase from the previous day's closing price.
A total volume of 220,902 shares were traded at the close of the day’s session.
In the last one week, shares of Medpace Holdings Inc have increased by +2.21%.
Medpace Holdings Inc's Key Ratios
Medpace Holdings Inc has a market cap of $8.54 billion, indicating a price to book ratio of 18.7194 and a price to sales ratio of 4.5628.
In the last 12-months Medpace Holdings Inc’s revenue was $1.67 billion with a gross profit of $925.11 million and an EBITDA of $343.02 million. The EBITDA ratio measures Medpace Holdings Inc's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Medpace Holdings Inc’s operating margin was 19.06% while its return on assets stood at 14.64% with a return of equity of 79.68%.
In Q2, Medpace Holdings Inc’s quarterly earnings growth was a positive 32.2% while revenue growth was a positive 31.2%.
Medpace Holdings Inc’s PE and PEG Ratio
- Forward PE
- 26.9542
- Trailing PE
- 32.5583
- PEG
- 1.97
Its diluted EPS in the last 12-months stands at $8.58 per share while it has a forward price to earnings multiple of 26.9542 and a PEG multiple of 1.97. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Medpace Holdings Inc’s profitability.
Medpace Holdings Inc stock is trading at a EV to sales ratio of 4.9456 and a EV to EBITDA ratio of 23.7841. Its price to sales ratio in the trailing 12-months stood at 4.5628.
Medpace Holdings Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- $1.41 billion
- Total Liabilities
- $852.44 million
- Operating Cash Flow
- $-8467000.00
- Capital Expenditure
- $8.45 million
- Dividend Payout Ratio
- 0%
Medpace Holdings Inc ended 2024 with $1.41 billion in total assets and $0 in total liabilities. Its intangible assets were valued at $1.41 billion while shareholder equity stood at $391.06 million.
Medpace Holdings Inc ended 2024 with $1.10 million in deferred long-term liabilities, $852.44 million in other current liabilities, 306000.00 in common stock, $-371022000.00 in retained earnings and $662.40 million in goodwill. Its cash balance stood at $39.14 million and cash and short-term investments were $39.14 million. The company’s total short-term debt was $55,000,000 while long-term debt stood at $0.
Medpace Holdings Inc’s total current assets stands at $378.93 million while long-term investments were $0 and short-term investments were $0. Its net receivables were $275.06 million compared to accounts payable of $33.61 million and inventory worth $0.
In 2024, Medpace Holdings Inc's operating cash flow was $-8467000.00 while its capital expenditure stood at $8.45 million.
Comparatively, Medpace Holdings Inc paid $0 in dividends in 2024.
Other key metrics
- Current Trading Price
- $279.54
- 52-Week High
- $281.84
- 52-Week Low
- $141.3
- Analyst Target Price
- $224.75
Medpace Holdings Inc stock is currently trading at $279.54 per share. It touched a 52-week high of $281.84 and a 52-week low of $281.84. Analysts tracking the stock have a 12-month average target price of $224.75.
Its 50-day moving average was $255.62 and 200-day moving average was $219.69 The short ratio stood at 3.23 indicating a short percent outstanding of 0%.
Around 4449.5% of the company’s stock are held by insiders while 8439% are held by institutions.
Frequently Asked Questions About Medpace Holdings Inc
Similar Industry Stocks (Diagnostics & Research)
Most Active
Top Gainers
Top Losers
About
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, it offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.